Reduced-Intensity Conditioning Hematopoietic Cell Transplantation Is an Effective Treatment for Patients with SLAM-Associated Protein Deficiency/X-linked Lymphoproliferative Disease Type 1
Keywords: X-linked lymphoproliferative disease; XLP; SLAM-associated protein; SH2D1A; Bone marrow transplant; Allogeneic hematopoietic cell transplant; Alemtuzumab; Reduced-intensity conditioning